Table of Contents

2019-2024 Global IGY Polyclonal Antibodies Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global IGY Polyclonal Antibodies Consumption 2014-2024
  • 2.1.2 IGY Polyclonal Antibodies Consumption CAGR by Region
• 2.2 IGY Polyclonal Antibodies Segment by Type
  • 2.2.1 Primary Antibody
  • 2.2.2 Secondary Antibody
• 2.3 IGY Polyclonal Antibodies Consumption by Type
  • 2.3.1 Global IGY Polyclonal Antibodies Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global IGY Polyclonal Antibodies Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global IGY Polyclonal Antibodies Sale Price by Type (2014-2019)
• 2.4 IGY Polyclonal Antibodies Segment by Application
  • 2.4.1 Academic Research
  • 2.4.2 Commercial
• 2.5 IGY Polyclonal Antibodies Consumption by Application
  • 2.5.1 Global IGY Polyclonal Antibodies Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global IGY Polyclonal Antibodies Value and Market Share by Application (2014-2019)
  • 2.5.3 Global IGY Polyclonal Antibodies Sale Price by Application (2014-2019)

3 Global IGY Polyclonal Antibodies by Players

• 3.1 Global IGY Polyclonal Antibodies Sales Market Share by Players
  • 3.1.1 Global IGY Polyclonal Antibodies Sales by Players (2017-2019)
  • 3.1.2 Global IGY Polyclonal Antibodies Sales Market Share by Players (2017-2019)
• 3.2 Global IGY Polyclonal Antibodies Revenue Market Share by Players
  • 3.2.1 Global IGY Polyclonal Antibodies Revenue by Players (2017-2019)
  • 3.2.2 Global IGY Polyclonal Antibodies Revenue Market Share by Players (2017-2019)
• 3.3 Global IGY Polyclonal Antibodies Sale Price by Players
• 3.4 Global IGY Polyclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global IGY Polyclonal Antibodies Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players IGY Polyclonal Antibodies Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 IGY Polyclonal Antibodies by Regions

• 4.1 IGY Polyclonal Antibodies by Regions
  • 4.1.1 Global IGY Polyclonal Antibodies Consumption by Regions
  • 4.1.2 Global IGY Polyclonal Antibodies Value by Regions
• 4.2 Americas IGY Polyclonal Antibodies Consumption Growth
• 4.3 APAC IGY Polyclonal Antibodies Consumption Growth
• 4.4 Europe IGY Polyclonal Antibodies Consumption Growth
• 4.5 Middle East & Africa IGY Polyclonal Antibodies Consumption Growth

5 Americas

• 5.1 Americas IGY Polyclonal Antibodies Consumption by Countries
  • 5.1.1 Americas IGY Polyclonal Antibodies Consumption by Countries (2014-2019)
  • 5.1.2 Americas IGY Polyclonal Antibodies Value by Countries (2014-2019)
• 5.2 Americas IGY Polyclonal Antibodies Consumption by Type
• 5.3 Americas IGY Polyclonal Antibodies Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC IGY Polyclonal Antibodies Consumption by Countries
  • 6.1.1 APAC IGY Polyclonal Antibodies Consumption by Countries (2014-2019)
  • 6.1.2 APAC IGY Polyclonal Antibodies Value by Countries (2014-2019)
• 6.2 APAC IGY Polyclonal Antibodies Consumption by Type
• 6.3 APAC IGY Polyclonal Antibodies Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe IGY Polyclonal Antibodies by Countries
  • 7.1.1 Europe IGY Polyclonal Antibodies Consumption by Countries (2014-2019)
  • 7.1.2 Europe IGY Polyclonal Antibodies Value by Countries (2014-2019)
• 7.2 Europe IGY Polyclonal Antibodies Consumption by Type
• 7.3 Europe IGY Polyclonal Antibodies Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa IGY Polyclonal Antibodies by Countries
  • 8.1.1 Middle East & Africa IGY Polyclonal Antibodies Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa IGY Polyclonal Antibodies Value by Countries (2014-2019)
• 8.2 Middle East & Africa IGY Polyclonal Antibodies Consumption by Type
• 8.3 Middle East & Africa IGY Polyclonal Antibodies Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 IGY Polyclonal Antibodies Distributors
• 10.3 IGY Polyclonal Antibodies Customer

11 Global IGY Polyclonal Antibodies Market Forecast

• 11.1 Global IGY Polyclonal Antibodies Consumption Forecast (2019-2024)
• 11.2 Global IGY Polyclonal Antibodies Forecast by Regions
  • 11.2.1 Global IGY Polyclonal Antibodies Forecast by Regions (2019-2024)
  • 11.2.2 Global IGY Polyclonal Antibodies Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global IGY Polyclonal Antibodies Forecast by Type
• 11.8 Global IGY Polyclonal Antibodies Forecast by Application

12 Key Players Analysis

• 12.1 Merck
  • 12.1.1 Company Details
  • 12.1.2 IGY Polyclonal Antibodies Product Offered
  • 12.1.3 Merck IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Merck News
• 12.2 IGY Life Sciences
  • 12.2.1 Company Details
  • 12.2.2 IGY Polyclonal Antibodies Product Offered
  • 12.2.3 IGY Life Sciences IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 IGY Life Sciences News
• 12.3 Abcam
  • 12.3.1 Company Details
  • 12.3.2 IGY Polyclonal Antibodies Product Offered
  • 12.3.3 Abcam IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Abcam News
• 12.4 Genway Biotech
  • 12.4.1 Company Details
  • 12.4.2 IGY Polyclonal Antibodies Product Offered
  • 12.4.3 Genway Biotech IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Genway Biotech News
• 12.5 Good Biotech
  • 12.5.1 Company Details
  • 12.5.2 IGY Polyclonal Antibodies Product Offered
  • 12.5.3 Good Biotech IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Good Biotech News
• 12.6 Gallus Immunotech
  • 12.6.1 Company Details
  • 12.6.2 IGY Polyclonal Antibodies Product Offered
  • 12.6.3 Gallus Immunotech IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Gallus Immunotech News
• 12.7 Creative Diagnostics
  • 12.7.1 Company Details
  • 12.7.2 IGY Polyclonal Antibodies Product Offered
  • 12.7.3 Creative Diagnostics IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Creative Diagnostics News
• 12.8 Agrisera
  • 12.8.1 Company Details
  • 12.8.2 IGY Polyclonal Antibodies Product Offered
  • 12.8.3 Agrisera IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Agrisera News
• 12.9 Innovagen AB
  • 12.9.1 Company Details
  • 12.9.2 IGY Polyclonal Antibodies Product Offered
  • 12.9.3 Innovagen AB IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Innovagen AB News
• 12.10 Capra Science
  • 12.10.1 Company Details
  • 12.10.2 IGY Polyclonal Antibodies Product Offered
  • 12.10.3 Capra Science IGY Polyclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Capra Science News
• 12.11 YO Proteins
• 12.12 GeneTex

13 Research Findings and Conclusion

Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.

According to this study, over the next five years the IGY Polyclonal Antibodies market will register a 13.5% CAGR in terms of revenue, the global market size will reach US$ 9 million by 2024, from US$ 4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in IGY Polyclonal Antibodies business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of IGY Polyclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

This study considers the IGY Polyclonal Antibodies value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Primary Antibody
Secondary Antibody
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Academic Research
Commercial

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global IGY Polyclonal Antibodies consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of IGY Polyclonal Antibodies market by identifying its various subsegments.
Focuses on the key global IGY Polyclonal Antibodies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the IGY Polyclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of IGY Polyclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.